P1-4: Growth

[P1-4-2] Incidences of Type 2 Diabetes Mellitus and Neoplasm in Growth Hormone Treated Children in Japan

^○Susumu Yokoya¹, Tomonobu Hasegawa², Keiichi Ozono³, Hiroyuki Tanaka⁴, Susumu Kanzaki⁵, Toshiaki Tanaka⁶, Kazuo Chihara⁷, Nan Jia⁸, Christopher Child⁹, Noriyuki Iwamoto¹⁰, Yoshiki Seino¹¹ (1.Department of Medical Subspecialties, National Center for Child Health and Development, 2.Department of Pediatrics, Keio University School of Medicine, 3.Department of Pediatrics, Osaka University Graduate School of Medicine / Faculty of Medicine, 4.Department of Pediatrics, Okayama Saiseikai General Hospital, 5.Department of Pediatrics, Tottori University Faculty of Medicine, 6.Tanaka Growth Clinic, 7.Department of Internal Medicine, Hyogo Prefectural Kakogawa Medical Center, 8.Lilly Research Laboratiries, Eli Lilly and Company, USA, 9.Lilly Research Laboratiries, Eli Lilly and Company, UK, 10.Medical Science, Eli Lilly Japan K.K., 11.JCHO Osaka Hospital)